• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Order-made medicine for cancer in the viewpoint of angiogenesis

Research Project

Project/Area Number 14370379
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Digestive surgery
Research InstitutionTokyo Medical and Dental University

Principal Investigator

ARII Shigeki  Tokyo Medical and Dental University, School of medicine, assistant professor, 大学院・歯学総合研究科, 教授 (50151171)

Co-Investigator(Kenkyū-buntansha) MORI Akira  Kyoto University, Graduate School of medicine, Faculty of medicine assistant, 医学研究科, 助手 (60324646)
KAWAMURA Toru  Tokyo Medical and Dental University, School of medicine, assistant, 医学部附属病院, 助手 (90322081)
TERAMOTO Kenichi  Tokyo Medical and Dental University, School of medicine, assistant, 大学院・歯学総合研究科, 助教授 (80197813)
SHIBATA Toru  Kyoto University, Graduate School of medicine, Faculty of Medicine assistant, 医学研究科, 助手 (40293857)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥14,600,000 (Direct Cost: ¥14,600,000)
Fiscal Year 2003: ¥5,400,000 (Direct Cost: ¥5,400,000)
Fiscal Year 2002: ¥9,200,000 (Direct Cost: ¥9,200,000)
Keywordsangiogenesis / order-made medicine / glycolysis / aerobic metabolism / anaerobic metabolism / vascular endothelial growth factor / hexokinase-II / hypoxia inducible factor-1 / 転移性肝癌 / 解糖系 / ヘキソキナーゼ / VEGF(vascular endothelial growth factor) / 遺伝子治療
Research Abstract

It has been thought that solid tumors require tumor angiogenesis in their growth. However, we sometimes encounter the tumors that grow rapidly despite their poor vascularity. This clinical observation suggest.s the existence of tumors that require little neoangiogenesis for their growth. In this research project, we analyzed the expressions of hexokinase, a key enzyme in glycolysis, and VEGE in hepatocellular carcinoma and rnetastatic liver cancer in relation to tumor vascularity, and the participation of hypoxia-inducible factor-1(HIF-1) was studied. Consequently, we obtained some informative evidence. In HCC, main energy source of the growth was derived from angiogenesis, whereas in metastatic tumors glycolysis induced by HIF-1 is the predominant energy source. In addition, it was suggested that cancer cells obtain energy for growth by switching the metabolic profile to glycolysis through HIP-i in hypoxic condition. Although many kinds of antiangiogenic therapies have been reported to be effective, it is assumed that some tumors might resist these therapies by acquiring energy for growth through increased glycolysis induced by HIF-1.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (9 results)

All Other

All Publications (9 results)

  • [Publications] Arii S.: "Hexokinase II and VEGF expression in liver tumors : correlation with hypoxia-inducible factor 1 alpha and its significance."J Hepatol.. 40. 117-123 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 有井 滋樹: "肝細胞癌-発癌・血管新生と血流イメージング"(株)メディカルトリビューン(発表予定). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arii S.: "Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance."J Hepatol.. 40. 117-123 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Arii S.: "Hexokinase II and VEGF expression in liver tumors : correlation with hypoxia-inducible factor 1 alpha and its significance."J Hepatol.. 40. 117-123 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 有井 滋樹: "肝細胞癌-発癌・血管新生と血流イメージング"(株)メディカルトリビューン(発表予定). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Arii S, Mori A, Kondo Y.: "Implication of tumor angiogenesis in the development of colon cancer and antiangiogenesis therapy. Gastrintinal function ; Regulation and disturbances"Excerpta Medica (Eds Matsuo Y, Kasuya Y, Muto A.). 19. 71-81 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 有井滋樹: "血管新生と肝細胞癌"Hepatica(Excerpta Medica). 21(3). 31-32 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 有井滋樹, 寺本研一: "浸潤転移・血管新生の分子生物学的解析と臨床意義"肝胆膵. 45(4). 555-560 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 有井滋樹, 安田誠一, 森 章, 寺本研一: "肝細胞癌の血管新生の分子機構.肝細胞癌の血行動態はどこまで分かったか"メヂカルトリビューン(監修神代正道、岡崎正敏、板井悠二). 6-13 (2001)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi